Our history  

Intana Bioscience AG was founded in September 2008 as spin out of GPC Biotech´s drug discovery and research facilities. The core technologies were established in the course of a BMBF-funded joint research project in cooperation with Prof. Dr. Roland Brock. We continuously work on improving the technologies and expanding our service offering through various collaborations, to better serve the drug discovery community.

We recently published with our customer Merck KGaA the use of FCCS to support the identification of Methionine Aminopeptidase-2 (MetAP-2) inhibitor M8891.

See our new publication on the quantifiaction of target occupancy in tissue:

Check out our new GPCR-ligand interaction assay!